TEST DIRECTORY

0 selected

Laboratory：Akiruno

○Oncomine DxTT Multi CDx (Thyroid Cancer) FF（Suspended beyond orders placed 06-14-2024）

CODE：00L85 6

  • TEST NAME SPECIMEN
    REQUIREMENT
    （ｍL）     CONTAINER CAP COLOR STORE
    TEMPERATURE
    (STABILITY)     TURNAROUND
    TIME (DAY)     METHODOLOGY REFERENCE RANGE
    (UNIT)
  • INACTIVE Specified days
    Oncomine DxTT Multi CDx (Thyroid Cancer) FF（Suspended beyond orders placed 06-14-2024）
    tissue
    100mg
    ARR Freeze
     6-11 Next Generation Sequencing (NGS)

    A method that uses a next-generation sequencer to simultaneously determine the base sequences of a huge number of DNA fragments.

COMMENT


The purpose of this study is to analyzeRET gene mutation and RET fusion gene in genomic DNA and RNA extracted from cancer tissue to determine the indication of the drugs listed in the attached table for thyroid cancer and medullary thyroid cancer.
The available days are Monday to Friday.
Please make sure that the material contains the tumor site before submitting it. Please avoid duplicate requests with other items. Since this test method is more susceptible to contamination, please handle the specimens with care when collecting them.
When requesting this test, please be sure to also request the nucleic acid extraction item (item code No.: M961 0).●Notes
After collecting the specimen, please process it immediately. Please note that if the number of cells in the submitted specimen is low, the test may not be possible.

CONTAINER

supplementary information

Notifications of URL changes/lab information added

ラボを選択してください

Choose a laboratory

Notifications of URL changes/lab information added

Laboratory List

Advanced search